Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 790
Clinical Pharmacology & Biopharmaceutics received 790 citations as per Google Scholar report
Clinical Pharmacology & Biopharmaceutics peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Genamics JournalSeek
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Potentiation of gentamicin induced nephrotoxicity by molsidomine in rats
4th International Pharma & Clinical Pharmacy Congress
Sabah H Akrawi, Marwan S Al Nimer
College of Clinical Pharmacy, King Faisal University, Al Hasa , KSA College of Medicine, Al Yarmouk University, Baghdad, Iraq
ScientificTracks Abstracts: Clin Pharmacol Biopharm
Abstract
Reactive oxygen metabolites have been implicated in gentamicin induced nephrotoxicity. This study tests whether or not nephrotoxicity of gentamicin is associated with cellular activation or lipid peroxidation and the use of vasodilator, molsidomine, plays a role in the renal lesion. Male Wister 200-300 g rats were distributed randomly into five groups, Saline treated group, Molsidomine treated group, Gentamicin treated group, Molsidomine + Gentamicin treated group, and Gentamicin + Ethanol treated group. The results showed that gentamicin induced nephrotoxicity was associated with a significant activation of cellular lipid peroxidation manifested by high serum and cortical tissue malondialdehyde, and the use of molsidomine aggravates this process. These data indicate that vasodilators and in particular those with nitric oxide (NO) dinating property may be extremely harmful when used with gentamicin.Biography
Sabah Akrawi, PhD, graduated from the College of Pharmacy/University of Kentucky/USA. He is an assoc. Prof. of Clinical Pharmacokinetic and Biopharmaceutic and a faculty member at the College of Clinical Pharmacy/King Faisal University/KSA. He supervised 17 postgraduate pharmacy students, and he has published more than 26 articles. He is a member of the scientific council of the KFU and chaired many defense committees for graduation of graduate students.
Email: shakrawi@hotmail.com
